Loading stock data…
$14.27-0.03 (-0.24%)
InMode Ltd.
InMode Ltd. in the Healthcare sector is trading at $14.27 with a market capitalization of $857M. Wall Street consensus targets $16.17 (3 analysts), implying a +13.3% move over the next 12 months. The stock is currently 14% below its 52-week high of $16.67, remaining 0.8% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $95.59M↑ | $82.02M↓ | $103.85M↑ | $93.17M↓ | $95.60M |
| Gross Profit | $71.52M↑ | $61.55M↓ | $81.30M↑ | $72.31M↓ | $76.45M |
| Operating Income | $12.26M↑ | $10.06M↓ | $25.99M↑ | $20.90M↓ | $22.88M |
| Net Income | $17.06M↑ | $11.56M↓ | $27.02M↑ | $21.86M↓ | $26.74M |
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe,...